Skip to content

Anxiety Disorders in Children - Association With Neurodevelopmental Delay/Disorder

Anxiety Disorders in Children - Association With Neurodevelopmental Delay/Disorder and Temperament/Personality. A Clinical Case-control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00553085
Enrollment
141
Registered
2007-11-05
Start date
2007-09-30
Completion date
2014-03-31
Last updated
2014-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders

Keywords

anxiety disorders, children, neurodevelopmental disorder, neurodevelopmental delay, temperament

Brief summary

The main objective of the study is to examine the relationship between anxiety disorders and neurodevelopmental disorder/delay in children aged 7- 13 years.

Detailed description

Project summary Anxiety disorders (AD's) in childhood are common and may cause great suffering.Childhood AD's may persist into adulthood and knowledge of important risk factors for development and maintenance of these disorders is essential.The development of AD's is due to a complex interaction between biological and environmental factors.This study will examine the relationship between AD's and two biological risk factors:1.Neurodevelopmental delays/disorders (NDD'S) in motor and cognitive function and 2.Temperament/personality.To date a few studies have consistently found that motor impairment is associated with childhood anxiety and predicts persistent anxiety in adolescence.The association between AD's and NDD's in cognitive functions such as language and attention is far less studied. In contrast, there is a huge research literature on temperament as a risk factor for AD's.The temperamental trait behavioural inhibition has been shown to be particularly associated with AD's.However, very few studies have examined the interplay between NDD's, temperament and anxiety.The study is a clinical case-control study of children aged 7-13 years with AD's referred to three different out-patient clinics.The participants will be assessed by diagnostic interviews, neuropsychological tests and temperament/personality instruments.Comparison groups are:1.children with ADHD (to compare AD's with another mental disorder related to NDD's) and 2.Non-referred children without a mental disorder. Follow-up at 6 months,1 and 5 years.A pilot study at two of the three out-patient clinics to be included,showed a sufficient sample size.Anticipated implications of the study include increased knowledge of biological risk factors and of latent neurological brain correlates,as well as treatment implications.Children with NDD's are often met with demands they cannot cope with due to their neurodevelopmental immaturity.To adjust the demands to the child's actual level of functioning is important.

Interventions

None listed

Sponsors

The Research Council of Norway
CollaboratorOTHER
University Hospital, Akershus
CollaboratorOTHER
Lovisenberg Diakonale Hospital
CollaboratorOTHER
The Hospital for Sick Children
CollaboratorOTHER
Regionsenter for barn og unges psykiske helse
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
7 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of anxiety disorder or ADHD or no diagnosis

Exclusion criteria

* Clinical diagnosis of PDD * mental retardation * children whose both parents do not speak Norwegian

Design outcomes

Primary

MeasureTime frame
Diagnosis of anxiety disorder5 years

Secondary

MeasureTime frameDescription
Children's global assessment scale (CGAS)5 yearsThe CGAS represents an assessment of the child's overall severity of disturbance with scores ranging from 1 (lowest functioning) to 100 (excellent functioning)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026